Lead Speaker: Jacqueline G. Hugtenburg – University of Curacao and VU University Medical Center Amsterdam
Speaker: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
Speaker: Robert Gross, MD, MSCE, FISPE – University of Pennsylvania
Lead Speaker: Jacqueline G. Hugtenburg – University of Curacao and VU University Medical Center Amsterdam
### @@@ Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics ### 1062823###Speaker###Assistant Professor###BWH Div of Pharmacoepidemiology and Pharmacoeconomics###Speaker: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
### @@@ Robert Gross, MD, MSCE, FISPE – University of Pennsylvania ### 1086967###Speaker###Professor of Medicine (ID) and Epidemiology###University of Pennsylvania###Speaker: Robert Gross, MD, MSCE, FISPE – University of Pennsylvania
###Lead Speaker: Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen
Speaker: Katja Taxis, MSc, PhD, FISPE – University of Groningen
Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
Lead Speaker: Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen
### @@@ Katja Taxis, MSc, PhD, FISPE – University of Groningen ### 1086972###Speaker###Professor###University of Groningen###Speaker: Katja Taxis, MSc, PhD, FISPE – University of Groningen
### @@@ Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto ### 1062862###Speaker###Assistant Professor###University of Toronto###Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
### @@@ Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet ### 1358115###Speaker###Assistant professor###Syddansk Universitet###Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
###Lead Speaker: Nivantha Naidoo, MBChB, DipPEC, MPH, MSc CER (she/her/hers) – Cerner Enviza an Oracle company
Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
Speaker: Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit
Speaker: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.
Lead Speaker: Nivantha Naidoo, MBChB, DipPEC, MPH, MSc CER (she/her/hers) – Cerner Enviza an Oracle company
### she/her/hers @@@ Deborah Layton, PhD, FISPE – PEPI Consultancy Limited ### 1656012###Moderator###Director###PEPI Consultancy Limited###Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
### @@@ Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit ### 1062612###Speaker###Head of Research###Institute of Pharmacovigilance Sciences, Drug Safety Research Unit###Speaker: Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit
### she/her/hers @@@ Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc. ### 1991390###Speaker###Executive Director, Head of Epidemiology and Risk Management Operation###BeiGene USA, Inc.###Speaker: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.
### he/him/hisLead Speaker: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
Speaker: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
Speaker: Elizabeth M. Garry, MPH, PhD – Aetion, Inc.
Lead Speaker: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### he/him/his @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1360328###Speaker###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Speaker: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Elizabeth M. Garry, MPH, PhD – Aetion, Inc. ### 1062756###Speaker###Head of Scientific Research###Aetion, Inc.###Speaker: Elizabeth M. Garry, MPH, PhD – Aetion, Inc.
###Lead Speaker: Geetha Iyer, MBBS, SM, PhD – Harvard School of Public Health
Speaker: Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson
Lead Speaker: Geetha Iyer, MBBS, SM, PhD – Harvard School of Public Health
### @@@ Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson ### 1046821###Speaker###Vice President and Global Head of Epidemiology###Johnson & Johnson###Speaker: Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson
###Lead Speaker: Harriet Dickinson, MPhil, PhD – Gilead
Lead Speaker: Dana Y. Teltsch, PhD, MSc – Takeda
Speaker: Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG
Speaker: Orla M. Doyle, PhD, BEng – Novartis
Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
Lead Speaker: Harriet Dickinson, MPhil, PhD – Gilead
### @@@ Dana Y. Teltsch, PhD, MSc – Takeda ### 1088160###Lead Speaker###Global Medical Evidence###Takeda###Lead Speaker: Dana Y. Teltsch, PhD, MSc – Takeda
### @@@ Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG ### 1088161###Speaker###Director TA Methodology Statistician RWE ###Boehringer Ingelheim Pharma GmbH & Co. KG###Speaker: Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG
### @@@ Orla M. Doyle, PhD, BEng – Novartis ### 1088162###Speaker###Director Data Science###Novartis###Speaker: Orla M. Doyle, PhD, BEng – Novartis
### @@@ Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA ### 1653783###Speaker###Associate Director of Epidemiology###IQVIA###Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hersLead Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
Speaker: Mackenzie M. Herzog, PhD, MPH (she/her/hers) – IQVIA
Speaker: David Maislin – Biomedical Statistical Consulting
Speaker: Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson
Lead Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
### @@@ Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA ### 1063015###Speaker###Chief Scientific Officer, IQVIA RWS###IQVIA###Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
### she/her/hers @@@ Mackenzie M. Herzog, PhD, MPH (she/her/hers) – IQVIA ### 1993856###Speaker###Director, Epidemiology###IQVIA###Speaker: Mackenzie M. Herzog, PhD, MPH (she/her/hers) – IQVIA
### she/her/hers @@@ David Maislin – Biomedical Statistical Consulting ### 1761991###Speaker###Managing Partner###Biomedical Statistical Consulting###Speaker: David Maislin – Biomedical Statistical Consulting
### @@@ Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson ### 1088172###Speaker###VP, MedTech Epidemiology and Real-World Data Sciences###Office of the Chief Medical Officer, Johnson & Johnson###Speaker: Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson
###Lead Speaker: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC
Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
Speaker: William G. Dixon, MD PhD – The University of Manchester
Speaker: Nabarun Dasgupta, MPH, PhD – UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA
Lead Speaker: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC
### she/her/hers @@@ Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA ### 1063015###Speaker###Chief Scientific Officer, IQVIA RWS###IQVIA###Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
### she/her/hers @@@ William G. Dixon, MD PhD – The University of Manchester ### 1062521###Speaker###Professor of Digital Epidemiology###The University of Manchester###Speaker: William G. Dixon, MD PhD – The University of Manchester
### @@@ Nabarun Dasgupta, MPH, PhD – UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA ### 1063005###Speaker###Senior Scientist###UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA###Speaker: Nabarun Dasgupta, MPH, PhD – UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA
###Lead Speaker: Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health
Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
Lead Speaker: Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health
### @@@ Deborah Layton, PhD, FISPE – PEPI Consultancy Limited ### 1656012###Moderator###Director###PEPI Consultancy Limited###Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
### @@@ Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions ### 1062596###Speaker###Director, Epidemiology###RTI Health Solutions###Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
###Lead Speaker: Jaclyn L. Bosco, PhD, MPH. FISPE – IQVIA
Speaker: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
Speaker: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
Lead Speaker: Jaclyn L. Bosco, PhD, MPH. FISPE – IQVIA
### @@@ Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc. ### 1088313###Speaker###Director of Observational Research###Amgen, Inc.###Speaker: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
### she/her/hers @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Speaker###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###Speaker: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Speaker###Associate Director for Science###US Food and Drug Administration###Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hersLead Speaker: Jennifer Gerber, PhD, MSc – GlaxoSmithKline
Speaker: Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc.
Speaker: Henok Tadesse Ayele, PhD – Merck & Co., Inc.
Speaker: Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA
Speaker: Robert T. Chen, MA, MD, FISPE – Brighton Collaboration
Speaker: Joanne Wu, ScD (she/her/hers) – Pfizer Inc
Speaker: Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc
Speaker: Deshayne B. Fell – University of Ottawa
Speaker: Annette Regan, PhD, MPH (she/her/hers) – University of San Francisco, San Francisco CA, USA
Speaker: Leah J. McGrath, PhD – Pfizer
Speaker: Christopher G. Prener, PhD – Pfizer, Inc
Lead Speaker: Jennifer Gerber, PhD, MSc – GlaxoSmithKline
### @@@ Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc. ### 1359188###Speaker###Senior Director###Infectious Disease Epidemiology, Moderna Therapeutics Inc.###Speaker: Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc.
### he/him/his @@@ Henok Tadesse Ayele, PhD – Merck & Co., Inc. ### 1062670###Speaker###Pricnicipal Scientist###Merck & Co., Inc.###Speaker: Henok Tadesse Ayele, PhD – Merck & Co., Inc.
### @@@ Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA ### 1659297###Speaker###Associate Director ###Office of Vaccines Research and Review, CBER/FDA###Speaker: Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA
### @@@ Robert T. Chen, MA, MD, FISPE – Brighton Collaboration ### 1088150###Speaker###Scientific Director###Brighton Collaboration###Speaker: Robert T. Chen, MA, MD, FISPE – Brighton Collaboration
### @@@ Joanne Wu, ScD (she/her/hers) – Pfizer Inc ### 1993416###Speaker###Associate Director, Epidemiology###Pfizer Inc###Speaker: Joanne Wu, ScD (she/her/hers) – Pfizer Inc
### she/her/hers @@@ Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc ### 1991413###Speaker###Director, Global Safety Epidemiology###Moderna, Inc###Speaker: Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc
### she/her/hers @@@ Deshayne B. Fell – University of Ottawa ### 1062677###Speaker###Dr. ###University of Ottawa###Speaker: Deshayne B. Fell – University of Ottawa
### @@@ Annette Regan, PhD, MPH (she/her/hers) – University of San Francisco, San Francisco CA, USA ### 1655874###Speaker###Associate Professor###University of San Francisco, San Francisco CA, USA###Speaker: Annette Regan, PhD, MPH (she/her/hers) – University of San Francisco, San Francisco CA, USA
### she/her/hers @@@ Leah J. McGrath, PhD – Pfizer ### 1659611###Speaker###Senior Director, Vaccines RWE###Pfizer###Speaker: Leah J. McGrath, PhD – Pfizer
### @@@ Christopher G. Prener, PhD – Pfizer, Inc ### 1991415###Speaker###Director, Vaccines RWE Biocurator Scientist###Pfizer, Inc###Speaker: Christopher G. Prener, PhD – Pfizer, Inc
###Lead Speaker: Andrea V. Margulis, MD ScD FISPE – RTI Health Solutions
Speaker: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine
Speaker: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
Speaker: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
Lead Speaker: Andrea V. Margulis, MD ScD FISPE – RTI Health Solutions
### @@@ Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine ### 1088175###Speaker######Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine###Speaker: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine
### @@@ Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University ### 1093997###Speaker###Professor of Epidemiology###Harvard University###Speaker: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Speaker######Brigham and Women's Hospital, Harvard Medical School###Speaker: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
Speaker: Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania
Speaker: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité
Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania ### 1357966###Speaker###Assistant Professor of Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Speaker: Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania
### @@@ Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité ### 1062567###Speaker###Associate Professor###Institute of Clinical Pharmacology and Toxicology, Charité###Speaker: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité
### he/him/hisLead Speaker: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
Lead Speaker: Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
Speaker: G. Niklas Norén, PhD – Uppsala Monitoring Centre
Speaker: Greg Powell, PharmD, MBA (he/him/his) – GlaxoSmithKline
Lead Speaker: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### she/her/hers @@@ Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1358805###Lead Speaker###Director, Division of Pharmacovigilance I###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Lead Speaker: Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hers @@@ G. Niklas Norén, PhD – Uppsala Monitoring Centre ### 1062637###Speaker###Chief Science Officer###Uppsala Monitoring Centre###Speaker: G. Niklas Norén, PhD – Uppsala Monitoring Centre
### @@@ Greg Powell, PharmD, MBA (he/him/his) – GlaxoSmithKline ### 1063261###Speaker###Senior Director, Safety and Clinical Innovation###GlaxoSmithKline###Speaker: Greg Powell, PharmD, MBA (he/him/his) – GlaxoSmithKline
### he/him/hisLead Speaker: Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency
Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc
Speaker: Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board
Speaker: Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago
Speaker: Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson
Speaker: Rania Mouchantaf, PhD (she/her/hers) – Health Canada
Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
Lead Speaker: Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency
### @@@ Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc ### 1088147###Lead Speaker###Senior DIrector###Evidera, Inc###Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc
### @@@ Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board ### 1659255###Speaker###Professor of drug regulatory science###Dutch Medicines Evaluation Board###Speaker: Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board
### @@@ Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago ### 1046822###Speaker###Dean and Professor, Parkinson School of Health Sciences and Public Health###Loyola University Chicago###Speaker: Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago
### @@@ Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson ### 1084118###Speaker###Manager###Janssen Research & Development, Johnson & Johnson###Speaker: Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson
### he/him/his @@@ Rania Mouchantaf, PhD (she/her/hers) – Health Canada ### 2016534###Speaker###A/Executive Director###Health Canada###Speaker: Rania Mouchantaf, PhD (she/her/hers) – Health Canada
### she/her/hers @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Speaker###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
###